comparemela.com

Latest Breaking News On - Karenl daniel - Page 1 : comparemela.com

Teladoc Health (NYSE:TDOC) Given New $16.00 Price Target at JPMorgan Chase & Co.

Teladoc Health (NYSE:TDOC) Given New $16.00 Price Target at JPMorgan Chase & Co.
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Piper-sandler
Laizer-kornwasser
Karenl-daniel
Teladoc-health
Hedge-funds-weigh-in-on-teladoc-health
Charles-schwab-investment-management-inc
Teladoc-health-inc
Barclays
Securities-exchange-commission
Teladoc-health-integrated-care

Analysts Set Expectations for Teladoc Health, Inc.'s Q1 2024 Earnings (NYSE:TDOC)

Analysts Set Expectations for Teladoc Health, Inc.'s Q1 2024 Earnings (NYSE:TDOC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Piper-sandler
Leerink-partnrs
Karenl-daniel
Teladoc-health
Panagora-asset-management-inc
Metlife-investment-management
Teladoc-health-inc
Great-west-life-assurance-co
Raymond-james-trust
Royal-bank

Teladoc Health (NYSE:TDOC) Stock Rating Reaffirmed by Leerink Partnrs

Teladoc Health (NYSE:TDOC – Get Free Report)‘s stock had its “market perform” rating reissued by equities research analysts at Leerink Partnrs in a research note issued to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Teladoc Health’s FY2025 earnings at ($0.78) EPS and FY2026 earnings at ($0.59) EPS. A number of other […]

Canada
United-states
Vidya-raman-tangella
Piper-sandler
Karenl-daniel
Leerink-partnrs
Insider-transactions-at-teladoc-health
Raymond-james-trust
Royal-bank
Metlife-investment-management
Analyst-recommendations-for-teladoc-health
Jpmorgan-chase-co

Teladoc Health (NYSE:TDOC) PT Lowered to $28.00

Teladoc Health (NYSE:TDOC – Free Report) had its target price trimmed by Canaccord Genuity Group from $34.00 to $28.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the health services provider’s stock. TDOC has been the subject of several other reports. Royal Bank of […]

Canada
United-states
Karenl-daniel
Vidya-raman-tangella
Teladoc-health-inc
Barclays
Securities-exchange-commission
Royal-bank
Mt-bank-corp
Forum-financial-management
Teladoc-health-company-profile
Hedge-funds-weigh-in-on-teladoc-health

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.